InvestorsHub Logo
Followers 9
Posts 529
Boards Moderated 0
Alias Born 04/13/2017

Re: None

Thursday, 03/15/2018 9:50:40 AM

Thursday, March 15, 2018 9:50:40 AM

Post# of 106837
This "Right to Try" failure has almost zero impact on the financial results of USRM. I know of no instance that a patient was dying and approached USRM for a "Life saving" Stem Cell Therapy! This is an absolute opportunity to take advantage of the price coming down on pure sympathy for the industry and nothing else. I bet the numbers are going to continue to be very strong and the stock is extremely undervalued here.